OnKure Therapeutics Appoints Jason Leverone, CPA, as Chief Financial Officer
February 08, 2022 07:00 ET
|
OnKure, Inc.
BOULDER, Colo., Feb. 08, 2022 (GLOBE NEWSWIRE) -- OnKure, Inc., a clinical-stage biopharmaceutical company discovering and developing the next generation of oncology precision medicines, today...